title: Apical hypertrophic cardiomyopathy: Present status.
abstract: Since the first description of apical hypertrophic cardiomyopathy in Japan 40years ago, contrasting information from all over the world has emerged regarding the natural history of the disease. This review provides an overview of incidence, phenotypic expressions, clinical features, prognosis, and management of this heterogeneous clinical entity, which may play a more relevant role in the burden of sudden cardiac death than previously thought.
authors: Aurora Cardiovascular Services, Aurora Sinai/Aurora St. Luke's Medical Centers, University of Wisconsin School of Medicine and Public Health, 2801 W. Kinnickinnic River Parkway, Ste. 840, Milwaukee, WI 53215, USA.
authors: M Fuad
authors: MF
authors: Jan
authors: Department of Clinical and Experimental Medicine and Pharmacology, University of Messina, Via Consolare Valeria n.12, 98100 Messina, Italy.
authors: Maria Chiara
authors: MC
authors: Todaro
authors: Department of Clinical and Experimental Medicine and Pharmacology, University of Messina, Via Consolare Valeria n.12, 98100 Messina, Italy.
authors: Lilia
authors: L
authors: Oreto
authors: Aurora Cardiovascular Services, Aurora Sinai/Aurora St. Luke's Medical Centers, University of Wisconsin School of Medicine and Public Health, 2801 W. Kinnickinnic River Parkway, Ste. 840, Milwaukee, WI 53215, USA. Electronic address: publishing14@aurora.org.
authors: A Jamil
authors: AJ
authors: Tajik
mesh_terms: D002312:Cardiomyopathy, Hypertrophic / Q000453:epidemiology*; D016757:Death, Sudden, Cardiac / Q000453:epidemiology* / Q000209:etiology; D014943:Global Health; D006801:Humans; D015994:Incidence; D011379:Prognosis; D015996:Survival Rate / Q000639:trends
keywords: Apical hypertrophic cardiomyopathy; Sudden cardiac death